RIL
EWTX icon

Rothschild Investment LLC’s Edgewise Therapeutics EWTX Stock Holding History

Rothschild Investment LLC’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09K Buy
150
+15
+11% +$517 ﹤0.01% 2174
2026
Q1 		$4.25K Hold
135
– – ﹤0.01% 2142
2025
Q4 		$3.35K Hold
135
– – ﹤0.01% 2099
2025
Q3 		$2.19K Sell
135
-25
-16% -$355 ﹤0.01% 2171
2025
Q2 		$2.1K Buy
160
+40
+33% +$577 ﹤0.01% 2043
2025
Q1 		$2.64K Buy
120
+30
+33% +$787 ﹤0.01% 1731
2024
Q4 		$2.4K Buy
90
+20
+29% +$637 ﹤0.01% 1698
2024
Q3 		$1.87K Buy
70
+35
+100% +$696 ﹤0.01% 1766
2024
Q2 		$630 Buy
35
+25
+250% +$436 ﹤0.01% 1878
2024
Q1 		$182 Buy
+10
New +$159 ﹤0.01% 1789

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rothschild Investment LLC's EWTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Edgewise Therapeutics (EWTX) stake by 11% in Q2 2026, buying an estimated $517 and bringing the position to 150 shares worth $6.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Rothschild Investment LLC first reported a position in EWTX in Q1 2024 and has held it in 10 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Rothschild Investment LLC held 150 shares of Edgewise Therapeutics worth $6.09K as of Q2 2026.
  • Rothschild Investment LLC bought 15 Edgewise Therapeutics shares in Q2 2026, an estimated $517.
  • Edgewise Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2174 holding.
  • Rothschild Investment LLC first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.